Expect New Cholesterol Injectables to be Saved as Add-On Meds

August 2015

You'll hear buzz about "PCSK9 inhibitors" for high cholesterol, Praluent (PRAL-you-ent, alirocumab) and Repatha (rih-PATH-ah, evolocumab).

These will be the first "biologic" injectable cholesterol meds.

They're getting lots of press because they can lower bad LDL cholesterol levels by about 60%...regardless of statin use.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Recognize When You're Receiving a 711 Call
COPD Stay Alert for Patients Switching to Stiolto From Other COPD Inhalers
Insulin Watch for Rxs Written Just as "Humalog KwikPen"
STIs Watch for STD Rxs That "Double Up" on Dispense Quantities
Pregnancy Expect to See Pregnancy Letter Ratings Removed from Drug Labels
Phosphate Don't be Surprised if Auryxia Doses Change Weekly
Opioids Expect to See Long-Term Buprenorphine Therapy for Opioid Dependence
Anticoagulants Consider a Calendar for Patients Using a Short-Term Blood Thinner
Prediabetes Help Spot Patients at Risk for Prediabetes
Photosensitivity Familiarize Yourself with Common Meds That Cause Sun Sensitivity
Practice Don't Automatically Substitute Between "Double-Duty" Products
Rheumatoid Arthritis Steer Patients Asking About Glucosamine or Chondroitin to the Pharmacist
Cholesterol Expect New Cholesterol Injectables to be Saved as Add-On Meds